Additionally, we evaluated the presence of EMT and cell stemness-related biomarkers in GC cells treated with TGF-β1 neutralizing antibody (20 μg/mL) and human recombinant TGF-β1 (20 ng/mL) in the co-culture system. Here, TGFB1 is linked to gastric cancer.